François Busquet: Why Europe needs the Hu...What is the Human Toxome Project? Its a wide-reaching programme aimed at helping us to reconsider how hazard/risk assessment has been performed over the last 50 years on marketed substances like chemicals, … more ➔
For real innovation, the pieces of the puz...I co-chaired a session at the Commissions Innovation in Healthcare conference recently, and learned a very interesting lesson there that is overwhelmingly obvious, yet overlooked in our continuing … more ➔
Marc de Garidel: Personalised medicine ...In the last 30 years, biotechnology has become a major source of innovation in combating untreated diseases and improving current treatments. A better understanding of the human genome rests at the heart … more ➔
Kurt Zatloukal: New framework for global r...The increase in lifestyle and ageing-associated diseases that has paralleled a rise in drug development costs along with the financial constraints of the global economy is putting enormous pressure … more ➔
Do the clouds on the pharma horizon have a...If Jane Austen was writing in the early 21st century in Europe, she could well have begun one of her novels with: It is a truth universally acknowledged, that a country in possession of a biotech sector, … more ➔
Maive Rute: Your role in establishing the...The societal and economic challenges facing Europe and the world are complex and interconnected. The Bioeconomy Strategy and Action Plan “Innovating for Sustainable Growth: a Bioeconomy for Europe”, … more ➔
Keeping it local – be afraid of the...In February, I heard of a slightly mad and very worrying trend in decisions handed down by the Court of Justice of the European Union (CJEU) with regard to IP issues handed up from the national level … more ➔
Robert Phillips & Rudi Balling: The b...The extensive coverage of the worldwide financial crises has masked a looming crisis in healthcare. In addition to the financial constraints affecting every part of society, healthcare also faces an … more ➔
